Burning Rock Biotech vs Personalis
Burning Rock Biotech and Personalis are similar in size: $75.1m and $69.6m of revenue in their latest fiscal years. Burning Rock Biotech grew faster (4.7% against -17.7%). Burning Rock Biotech kept more of each dollar of sales as profit: a net margin of -10.3% against -116.7%.
| Latest fiscal year | Burning Rock BiotechBNR, 2025 | PersonalisPSNL, 2025 |
|---|---|---|
| Revenue | $75.1m | $69.6m |
| Revenue growth | 4.7% | -17.7% |
| Net income | −$7.7m | −$81.3m |
| Operating margin | — | -126.4% |
| Net margin | -10.3% | -116.7% |
| Return on equity | -9.9% | -35.0% |
| Free cash flow | −$4.7m | −$79.5m |
| Cash | $68.4m | $124m |
| Total debt | $243,097 | $0 |
| Debt to equity | — | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 260 |
| Market value | $115m | $1.68bn |
| Price vs our value range | — | — |
| Moat score | — | 11 (Weak) |
| Insider trades, 12 months | 8 buys, 0 sales | 0 buys, 16 sales |